Evaluating Artificial Intelligence-Based Clinical Decision Support for Sepsis and ARDS
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 355 people enrolled
- Started
- 5 Dec 2025
- Ended
- 3 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Artifical Intelligence-Generated Treatment Recommendations
- Record updated
- 23 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Working as a physician (i.e., MD, DO) or an advanced practice provider (i.e., nurse practitioner, physician assistant)
- Working at a hospital or medical center in medical critical care, anesthesia critical care, surgical critical care, or emergency medicine
Who cannot take part
- Has not completed a residency training program (i.e., medical intern or resident)
Where in United States
- University of PennsylvaniaPhiladelphia, United States
About the trial
What the trial wants to find out
Sepsis and acute respiratory distress syndrome (ARDS) are common in intensive care units. Managing sepsis and ARDS is inherently complex and requires making numerous decisions under uncertainty. Artificial intelligence (AI) clinical decision support systems (CDSSs) offer a promising approach to support care management for sepsis and ARDS.
Read full original descriptionShow less
The goal of this randomized, survey-based study is to compare treatment recommendations enacted by clinicians to those generated by an AI CDSS. The study will investigate whether an AI CDSS can generate treatment recommendations that are safe, appropriate, and indistinguishable to those provided by real clinicians.
In this study, participants (i.e., critical care clinicians) will review a series of critical care cases (vignettes) in an electronic survey. Each vignette will contain a de-identified case of a patient with sepsis and ARDS as well as treatment recommendations for the case. Participants will assess the safety and appropriateness of each treatment recommendations and answer whether they think the treatment recommendations came from the clinician or an AI CDSS.
The 2 groups in the trial
- Artificial IntelligenceTreatment being tested
Critical care cases / vignettes in this arm will contain treatment recommendations generated by an artificial intelligence-based clinical decision support system. Each participant will review four vignettes from this arm.
Treatment: Artifical Intelligence-Generated Treatment Recommendations
- Human ClinicianNo study treatment, for comparison
Critical care cases / vignettes in this arm will contain treatment recommendations that were enacted by the clinician in the actual case. Each participant will review four vignettes from this arm.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluating Artificial Intelligence-Based Comprehensive Clinical Decision Support for Sepsis and ARDS
- Publications
- Record updated
- 23 July 2026